Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetics study of AMG 794 in Claudin-6–positive cancers, including non-small cell lung cancer and …
-
CLINICAL_TRIALS other · 2025-10-07Clinical Trial Update: BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 trial of BPI-361175 in advanced non-small cell lung cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer [Phase 2]
A phase 2 trial is evaluating the combination of atezolizumab and cobimetinib in patients with metastatic, recurrent, or refractory non-smal…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X) [Phase 2]
Phase 2 trial evaluates whether radiation given before a tyrosine kinase inhibitor delays progression in advanced driver-mutated non-small c…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy
A clinical trial investigating whether microbiome analysis can predict treatment response and toxicity after concurrent chemoradiotherapy in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with BDB001 and immunogenic radiotherapy for advanced solid tumors is currentl…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation. [Phase 2]
Phase 2 study evaluating JBI-802 alone or in combination with pembrolizumab for non-small cell lung cancer with an STK11 mutation; currently…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Immunotherapy in Patient With Poor General Condition [Phase 2]
A Phase 2 trial update reports on immunotherapy for patients with advanced non-small cell lung cancer and poor general condition. The study …
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated safety and preliminary effectiveness of BGB-A445 in combination with tislelizumab in participants with advanced…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors [Phase 2]
Phase 2 monotherapy trial of tovorafenib (DAY101) in melanoma and other solid tumors was terminated, with results posted.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of adding a short course of a MEK inhibitor to chemoimmunotherapy…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC [Phase 2]
A Phase 2 trial evaluating GFH018 in combination with toripalimab and concurrent chemoradiotherapy for stage III non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating infusion of NY-ESO-1–specific TCR-engineered lymphocytes in patients with NY-ESO-1-expressing…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Study With Various Immunotherapy Treatments in Participants With Lung Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of various immunotherapy treatments for advanced non-small cell lung cancer, sponsored …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Intrathecal Double Checkpoint Inhibition [Phase 1]
This Phase 1 clinical trial from the University of Zurich investigates intrathecal double checkpoint inhibition for leptomeningeal metastasi…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) [Phase 2]
A Phase 2 study evaluating SAR444245 in combination with other anticancer therapies for pleural mesothelioma and non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
Update on a clinical trial evaluating plasma next-generation sequencing to assess and characterize patients with ALK resistance in Non-Small…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: DC/NK Cell Therapy [Phase 2]
Phase 2 clinical trial investigating DC/NK cell therapy for non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: The IVO-LUNG Study [Phase 2]
The IVO-LUNG Study is a Phase 2 clinical trial for Non-Small Cell Lung Cancer (Stage III) that is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study [NA]
A randomized trial evaluating circulating DNA to improve outcomes in oncology is currently recruiting for colorectal cancer and non-small ce…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD [NA]
This ClinicalTrials.gov listing describes an ongoing trial investigating adaptive therapy for patients with resected stage I A2 to II non-sm…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013) [Phase 2]
Phase 2 trial evaluating serplulimab plus chemotherapy as neoadjuvant and adjuvant therapy for resectable non-small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: ArticuGrasp Trial: New Flexible Tool vs Standard Grasper for Lung Cancer Node Removal in Keyhole Chest Surgery [NA]
A completed clinical trial comparing the ArticuGrasp flexible surgical tool to a standard grasper for mediastinal lymph node removal during …
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients [Phase 1]
This is a Phase 1 clinical trial update evaluating APG-1252 in combination with osimertinib for EGFR TKI-resistant non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations [Phase 2]
A Phase 2 clinical trial update investigating the first-line use of amivantamab, lazertinib, and pemetrexed in recurrent/metastatic EGFR-mut…